Medigen to recruit 3,700 volunteers for COVID vaccine phase 2 trials

Medigen Vaccine Biologics Corp. (MVC), a Taiwanese company whose COVID-19 vaccine candidate has been approved for second-stage clinical trials, said Wednesday that it will recruit 3,700 volunteers to participate in the trials over the next three months.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)